<SEC-DOCUMENT>0001176256-15-000260-index.html : 20150901 <SEC-HEADER>0001176256-15-000260.hdr.sgml : 20150901 <ACCEPTANCE-DATETIME>20150724173033 <PRIVATE-TO-PUBLIC> ACCESSION NUMBER: 0001176256-15-000260 CONFORMED SUBMISSION TYPE: F-3/A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20150724 DATE AS OF CHANGE: 20150804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-3/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-205659 FILM NUMBER: 151005373 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>F-3/A <SEQUENCE>1 <FILENAME>nymoxf3a1.htm <DESCRIPTION>AMENDMENT NO. 1 TO FORM F-3 REGISTRATION STATEMENT <TEXT> Document 1 - file: nymoxf3a1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>exhibit5-1.htm <DESCRIPTION>OPINION OF ZOUVAS & ASSOCIATES LLP <TEXT> Document 3 - file: exhibit5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>exhibit23-1.htm <DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <TEXT> Document 4 - file: exhibit23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>exhibit5-1x1x1.jpg <TEXT> Document 5 - file: exhibit5-1x1x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>exhibit23-1x1x1.jpg <TEXT> Document 6 - file: exhibit23-1x1x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image_001.jpg <TEXT> Document 7 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>CORRESP <SEQUENCE>8 <FILENAME>filename8.htm <TEXT> Document 8 - file: filename8.htm
</DOCUMENT> </SEC-DOCUMENT>